Elite Pharmaceuticals Inc 's ability to collect accounts receivable sequentially worsen to 3.11, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Elite Pharmaceuticals Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 117 days, from 103 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 522 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 3128 to 3343.

What is Receivable Turnover Ratio?
What is Elite Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ELTP Receivables Turnover Ratio	(Jun 30 2026) I. Quarter	(Mar 31 2026) IV. Quarter	(Dec 31 2025) III. Quarter	(Sep 30 2025) II. Quarter	(Jun 30 2025) I. Quarter
Y / Y Receivable Change	39.27 %	104.46 %	50.14 %	90.6 %	76.79 %
Y / Y Revenue Change	-17.52 %	26.17 %	119.23 %	98.23 %	112.32 %
Receivable Turnover Ratio (TTM)	3.11	3.54	4.09	3.87	3.91
ELTP's Total Ranking	# 3343	# 3128	# 3149	# 3230	# 3634
Accounts Receivable average collection period days	117	103	89	94	93
Seq. Receivable Change	-15.53 %	104.46 %	-28.54 %	12.85 %	24.01 %
Seq. Revenue Change	-20.6 %	31.64 %	-14.19 %	-8.04 %	21.46 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 173
Healthcare Sector	# 523
Overall Market	# 3343

Receivable Turnover Ratio Statistics
High	Average	Low
14.48	7.23	3.11
(Mar 31 2016)		(Jun 30 2026)

ELTP Company Profile • Back to ELTP Efficiency Comparisons • Compare ELTP Receivables Turnover Ratio to its Competitors

Financial Statements
Elite Pharmaceuticals Inc 's Accounts Receivable	$ 50 Millions	Visit ELTP's Balance sheet
Elite Pharmaceuticals Inc 's Sales TTM	$ 140 Millions	Visit ELTP's Income Statement
Sources of ELTP's Revenues		Visit ELTP's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ELTP's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ELTP's Growth Rates	ELTP's Roa	ELTP's Inventory Turnover Ratio	ELTP's Dividend Comparisons
ELTP's Profitability Ratios	ELTP's Roi	ELTP's Asset Turnover Ratio	ELTP's Dividend Growth
ELTP's Valuation Ratios	ELTP's Roe	ELTP's Financial Strength Ratios	ELTP's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Natera Inc	7.61	$ 2,707.077 Millions	$ 355.618 Millions
Quest Diagnostics Inc	7.56	$ 11,560.000 Millions	$ 1,529.250 Millions
Fortress Biotech Inc	7.55	$ 69.983 Millions	$ 9.266 Millions
Iridex Corp	7.49	$ 51.044 Millions	$ 6.816 Millions
Novocure Limited	7.46	$ 699.193 Millions	$ 93.686 Millions
Intuitive Surgical Inc	7.46	$ 11,296.300 Millions	$ 1,513.950 Millions
Transmedics Group Inc	7.43	$ 668.468 Millions	$ 89.962 Millions
Beta Bionics Inc	7.43	$ 119.513 Millions	$ 16.092 Millions
Renovorx Inc	7.40	$ 1.976 Millions	$ 0.267 Millions
Maravai Lifesciences Holdings Inc	7.39	$ 207.886 Millions	$ 28.147 Millions
Lucid Diagnostics Inc	7.33	$ 5.445 Millions	$ 0.742 Millions
Foxo Technologies Inc	7.27	$ 24.846 Millions	$ 3.420 Millions
Safe Pro Group Inc	7.23	$ 2.881 Millions	$ 0.399 Millions
Rhythm Pharmaceuticals Inc	7.18	$ 239.918 Millions	$ 33.429 Millions
Travere Therapeutics Inc	7.10	$ 591.330 Millions	$ 83.339 Millions
Angiodynamics Inc	7.08	$ 317.726 Millions	$ 44.853 Millions
Pulmonx Corporation	7.07	$ 87.393 Millions	$ 12.356 Millions
Sutro Biopharma Inc	6.98	$ 45.702 Millions	$ 6.545 Millions
Edwards Lifesciences Corporation	6.98	$ 6,512.500 Millions	$ 933.400 Millions
Beyond Air Inc	6.98	$ 6.677 Millions	$ 0.957 Millions
Quidelortho Corp	6.92	$ 2,674.200 Millions	$ 386.400 Millions
Myriad Genetics Inc	6.91	$ 805.900 Millions	$ 116.650 Millions
Ceribell Inc	6.90	$ 101.804 Millions	$ 14.749 Millions
Stryker Corp	6.89	$ 25,837.000 Millions	$ 3,749.000 Millions
Nephros Inc	6.83	$ 21.686 Millions	$ 3.173 Millions
Medpace Holdings Inc	6.82	$ 2,782.288 Millions	$ 408.189 Millions
Opko Health Inc	6.79	$ 587.896 Millions	$ 86.589 Millions
Atara Biotherapeutics Inc	6.79	$ 6.452 Millions	$ 0.950 Millions
Rapid Micro Biosystems Inc	6.76	$ 34.545 Millions	$ 5.111 Millions
Universal Health Services Inc	6.75	$ 18,114.487 Millions	$ 2,683.492 Millions

Date modified: 2026-09-01T19:54:32+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.